Comgest Global Investors S.A.S. Abcam PLC Transaction History

Comgest Global Investors S.A.S.

  • $6.31 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023
BUY
$12.62 - $24.47 $8.19 Million - $15.9 Million
649,127 Added 88.66%
1,381,268 $33.8 Million
Q1 2023

May 15, 2023
BUY
$12.98 - $17.1 $9.5 Million - $12.5 Million
732,141 New
732,141 $9.85 Million

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Comgest Global Investors S.A.S. Portfolio

Follow Comgest Global Investors S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comgest Global Investors S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Comgest Global Investors S.A.S. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email